cell therapy manufacturing
cell therapy manufacturing
Regeneron Joins Forces with 2seventy for Breakthrough Cancer Treatments
Regeneron partners with 2seventy to boost cell therapy pipeline 🤝💼. Aims to develop immune cell therapies for cancer treatment 🧪🔍.
Revolutionary Kyverna Cuts CAR-T Production to 3 Days
📰 CAR-T, a gamechanger in cancer treatment, could revolutionize patient access and save lives with Kyverna's 3-day process. 💉🔬
Revolutionary Startup Aims to Transform Cell and Gene Therapies
📰 Frustration with CDMOs fuels ambition for advanced therapy startup GDMC, offering end-to-end solutions for cell and gene therapies. 💡💪🌱🧬
Breakthrough Technology Solving Cell Therapy Bottleneck
🧬 The emergence of CRISPR-based gene editing has revolutionized cell therapy research. 🔬 However, there is a significant bottleneck in the development and manufacturing of these therapies. ⚙️ Critical to CRISPR-based gene editing is the effective delivery of editing components to target cells. 🔬 Scaling the process for industrial manufacturing is a challenge, especially for therapies that require ex vivo editing of patient cells. ⚡ Electroporation technology, specifically flow electroporation, offers a solution to this bottleneck. 📈 Flow electroporation can transfect billions of cells at a time, providing scalability and process standardization. 💉 This technology is already being used to enable CRISPR-based therapies and has played a critical role in the commercial approval of the first CRISPR-based cell therapy. 🧬 As companies and scientists develop more advanced cellular therapies, flow electroporation will continue to expand access to non-viral approaches. 🌍 While questions remain about the long-term safety and efficacy of genome editing therapies, CRISPR-related technologies offer new avenues for treating diseases.
Boosting Manufacturing Efficiency: AI’s Role in Cutting Costs and Enhancing Therapies
🧪 AI accelerates commercialization strategies by cutting costs and improving processes in advanced therapy manufacturing. 🔬 5 of batches fail, impacting health and revenues. 🧠 AI is crucial for complex therapies. 💰 Manufacturers need to optimize processes and reduce costs. 🌐 AI enables learning transfer and supports decision-making. 📈 Industry 4.0 will use machine learning for real-time predictions and support.
World’s First CRISPR Cell Therapy Approved for Sickle Cell – Solvias to Perform Testing
📰 Solvias will perform release testing on CASGEVY, the world's first CRISPRCas9 genome-edited cell therapy. 🧪💊🔬✅🌍
Exciting Collaboration Boosts Excellos’ Cell Therapy!
📣 CDMO Excellos teams up with Vitalant for cell therapy advancements! 💉🧪 Excellos' programs will benefit from Vitalant's services, boosting their biotech offerings. 🚀
Pluri Revolutionizes Cell Therapy with Expanded CDMO Services
🌟 Pluri, a cell therapy pioneer, ventures into the CDMO space, offering end-to-end services for biotech development. 🚀
Sleep Tech Startup Onera Health Raises $32M in Funding
📢 Sleep diagnostics specialist Onera Health raises €30m ($32m) in Series C round, accelerating manufacturing and expanding devices. 💤💰
Massive Growth in UK ADC Facility Boosts Biopharmaceutical Industry
📰 CDMO Piramal bulks out UK ADC facility! 💊🧪 Enhanced capabilities to meet growing demand in biopharmaceutical industry. 🌍👥
